BioCryst Pharmaceuticals
BCRX
#5062
Rank
S$2.06 B
Marketcap
S$9.83
Share price
-3.07%
Change (1 day)
-5.18%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - P/B ratio

P/B ratio as of December 2025 : -4.12

According to BioCryst Pharmaceuticals 's latest financial reports the company has a price-to-book ratio of 2.66419.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

BioCryst Pharmaceuticals - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31N/A-100%
2024-12-31-3.3624.59%
2023-12-31-2.69-62.93%
2022-12-31-7.26-68.81%
2021-12-31-23.3-65.89%
2020-12-31-68.3-591.41%
2019-12-3113.9-22.97%
2018-12-3118.0212.76%
2017-12-315.77-98.05%
2016-12-312961765.24%
2015-12-3115.937.12%
2014-12-3111.6-102.9%
2013-12-31-399150.56%
2012-12-31-159-2210.4%
2011-12-317.54112.56%
2010-12-313.557.92%
2009-12-313.29191.24%
2008-12-311.13-68.77%
2007-12-313.62-77.38%
2006-12-3116.093.53%
2005-12-318.2692.63%
2004-12-314.29-0.37%
2003-12-314.30918.74%
2002-12-310.4224

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Repligen
RGEN
4.46-208.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
1.77-142.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
2.94-171.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-7.17 73.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
7.01-270.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
3.27-179.38%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
4.61-212.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
1.09-126.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
7.34-278.14%๐Ÿ‡บ๐Ÿ‡ธ USA